For Investors

Press Releases

ReWalk Robotics Reports Second Quarter 2019 Financial Results

08/08/19

— 2019 second quarter total revenue of $0.9 million — — Received FDA & CE clearance for ReStore Exo-Suit — YOKNEAM ILIT, Israel / MARLBOROUGH, Mass. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the

ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019

08/06/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Aug. 06, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2019 financial results on Thursday, August 8, 2019 , before the U.S.

ReWalk Robotics Announces Closing of Registered Direct Offering for $5.0 Million Priced At-the-Market

06/12/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , June 12, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing of its previously announced registered direct offering of approximately 833,334 ordinary shares at a purchase price of

ReWalk Robotics Announces Pricing of Registered Direct Offering for $5 Million

06/10/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 833,334 ordinary

ReWalk Robotics Announces Exercise of Warrants Resulting in Cash Proceeds of $10.8 Million

06/05/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , June 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), today announced the agreement by several accredited investors of its ordinary share purchase warrants to exercise and purchase 1,446,665 of its ordinary

FDA Issues Clearance for the ReStore™ Exo-Suit, the First Soft Robotic System for Stroke Therapy

06/04/19

New age innovation offers versatile, affordable medical device to U.S. rehab clinics to treat millions of patients with gait impairment MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, June 4, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer

ReWalk Robotics Receives CE Mark for ReStore™ Exo-Suit Stroke Rehabilitation Device

05/29/19

Advent of the Soft Exo-Suit Generation expands assistive robotic therapy for stroke survivors MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 29, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with

ReWalk Robotics Appoints Chunlin (Allen) Han to its Board of Directors

05/20/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , May 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company has appointed Mr. Chunlin (Allen) Han to the board of directors of the Company (the “Board”). Ms.

ReWalk Robotics Reports First Quarter 2019 Financial Results

05/07/19

— 2019 first quarter total revenue of $1.6 million — — Gross margin record of 59% — — On track with ReStore Exo-Suit launch timeline — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , May 07, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its

ReWalk Robotics to Report First Quarter 2019 Financial Results on May 7, 2019

05/03/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , May 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2019 financial results on Tuesday, May 7, 2019 , before the U.S.

ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)

04/26/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 26, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has regained compliance with Nasdaq Listing Rules 5550(b) (“Rule 5550(b)”) and 5550(a)(2) (“Rule 5550(a)(2)”).

ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again

04/25/19

Independent reviewer authorizes coverage of ReWalk system for another paralyzed individual, the 17th by a regional BCBS plan MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 25, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that an